Manulife (Manufacturers Life Insurance)
KNTE

Manulife (Manufacturers Life Insurance)’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,062
Closed -$75.4K – 3089
2023
Q1 		$75.4K Hold
12,062
– – ﹤0.01% 2803
2022
Q4 		$73.6K Buy
12,062
+168
+1% +$1.37K ﹤0.01% 2865
2022
Q3 		$142K Sell
11,894
-360
-3% -$4.71K ﹤0.01% 2710
2022
Q2 		$155K Buy
12,254
+196
+2% +$1.82K ﹤0.01% 2777
2022
Q1 		$136K Sell
12,058
-2,576
-18% -$28.4K ﹤0.01% 2897
2021
Q4 		$259 Buy
14,634
+829
+6% +$17.5K ﹤0.01% 2719
2021
Q3 		$318K Buy
+13,805
New +$301K ﹤0.01% 2626
2021
Q2 		– Sell
-7,566
Closed -$236K – 3312
2021
Q1 		$236K Buy
+7,566
New +$264K ﹤0.01% 2778

Other funds holding KNTE

FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $508M AUM 163.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s KNTE Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2023, closing a stake of 12,062 shares — an estimated $75.4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in KNTE in Q1 2021 and held it in 8 quarters. The position peaked at $318K in Q3 2021. 72 funds tracked by Wall St. Rank hold KNTE as of Q2 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 12,062 Kinnate Biopharma Inc. Common Stock shares in Q2 2023, an estimated $75.4K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Kinnate Biopharma Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Manulife (Manufacturers Life Insurance)'s Kinnate Biopharma Inc. Common Stock position peaked at $318K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.